Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G Babiker, Laura Richert, Jean-Michel Molina, Elizabeth C George, Andrea Antinori, Jose R Arribas, Jesper Grarup, Fleur Hudson, Christine Schwimmer, Juliette Saillard, Cédrick Wallet, Per O Jansson, Clotilde Allavena, Remko Van Leeuwen, Jean-François Delfraissy, Stefano Vella, Geneviève Chêne, Anton Pozniak, NEAT001/ANRS143 Study Group

    140 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab